Moreover, their research evaluated the potential of GDNF for being a biomarker for OSA, achieving spectacular results with specificity and sensitivity of 100% and an area under the curve equal to 1.00 [125]. This evidence concerns the gene GDNF and obstructive sleep apnea syndrome.